Feasibility assessment of an ambulatory monitoring and management of chronic obstructive pulmonary disease

The George Institute for Global Health0 个研究点目标入组 20 人开始时间: 2021年5月12日最近更新: 2021年5月17日

适应症

试验速览

暂无简介。

•1. Evidence of spirometrically confirmed airflow obstruction, defined as a post-bronchodilator FEV1/FVC ratio <0.7 and post-bronchodilator FEV1 between 30% and 70% predicted, recorded within 1 year of screening
•2. Report one or more of the following symptoms within the preceding two weeks: shortness of breath, chronic cough and sputum
•3. Hospitalisation for worsening COPD (exacerbation) on one or more occasions in the two years prior to commencement of study procedures
•4. Be ambulatory and self-caring at the time of recruitment

•1. Have experienced an exacerbation in the 30 days prior to screening
•2. In the opinion of the investigator will not complete the study or adhere to the intervention
•3. In the opinion of the investigator, have an inadequate mastery of English to communicate with study staff
•4. Is unable to independently provide consent

发起方